Investor Contact
Home »
Address:
Fl.15, Dongguan Plaza, No.618 Jiangnan Avenue, Binjiang District, Hangzhou, 310053, China
Phone:
+86-571-89986795
Email:
Fl.15, Dongguan Plaza, No.618 Jiangnan Avenue, Binjiang District, Hangzhou, 310053, China
+86-571-89986795
We are committed to supporting our clients in their clinical development in the best possible way.
We are committed to supporting our clients in their clinical development in the best possible way.
We are committed to supporting our clients in their clinical development in the best possible way.
We are committed to supporting our clients in their clinical development in the best possible way.
We are committed to supporting our clients in their clinical development in the best possible way.
We are committed to supporting our clients in their clinical development in the best possible way.
A deep interpretation of newly updated Measures for the Administration of Drug Registration in China.
After the pilot program in ten provinces and municipal cities for 3 years, the MAH system becomes one of the twelve chapters of the revised Drug Administration Law, which was put into effect since De 1, 2019.
On March 30, 2020, the revised Drug Registration Regulation (DRR) was issued by the State Administration for Marketing Regulation and will be put into effect from July 1, 2020
We are committed to supporting our clients in their clinical development in the best possible way.